CorMedix, Inc. (CRMD)
7.58
-0.11
(-1.43%)
USD |
NASDAQ |
Feb 09, 16:00
7.66
+0.08
(+1.06%)
After-Hours: 18:34
CorMedix EPS Diluted (Quarterly) : 1.259 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| Pfizer Inc. | -0.2898 |
| Arcutis Biotherapeutics, Inc. | 0.0558 |
| ANI Pharmaceuticals, Inc. | 1.133 |
| Castle Biosciences, Inc. | -0.0172 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 108.56M |
| Revenue (Quarterly) | 104.28M |
| Total Expenses (Quarterly) | -4.288M |
| Enterprise Value | 554.56M |
| Gross Profit Margin (Quarterly) | 89.26% |
| Earnings Yield | 27.09% |
| Operating Earnings Yield | 19.01% |
| Normalized Earnings Yield | 27.01 |